@taylorreidcoachin's testosterone routine claims fact-checked
Quick answer
The creator describes a subcutaneous testosterone regimen of approximately 12mg per week divided across three injections, implying a preparation concentrated at roughly 20mg/mL. This falls within the lower-to-mid range seen in some women's TRT protocols, but the Global Consensus Position Statement (Wierman et al., 2019) emphasizes that dosing in women must be guided by serum testosterone measurements to avoid supraphysiological androgen exposure. No mention of lab monitoring, baseline levels, or prescribing physician is made in the transcript.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @taylorreidcoachin actually say?
She describes injecting testosterone three times a week, 20 units per injection, which she calculates as four milligrams per shot and 12 milligrams total weekly. She's clear this is her personal routine: "this is just what I do." That disclaimer matters, and she repeats it twice. What she does not clarify is the concentration of her testosterone preparation, what ester she's using, or whether she's under clinical supervision. The math she presents only works if her formulation is a specific concentration, and she never states that concentration on screen.
The omission is a real problem for viewers trying to reverse-engineer her protocol. "20 units" is a syringe measurement, not a dose in milligrams. Without knowing the concentration in mg/mL, those numbers mean nothing to someone else drawing up a syringe at home.
Does the science back this up?
Low-dose testosterone therapy for women is legitimately studied and used clinically. The dosing range she describes, around 12mg per week, sits at the higher end of what's typically used in women's TRT, but it's not outside the range seen in clinical practice or research. The evidence base, however, is still developing.
Davis et al. (2019, The Lancet Diabetes and Endocrinology) published a systematic review finding that testosterone therapy in women improved sexual function and some quality-of-life markers, but noted a lack of long-term safety data beyond 24 months. The Global Consensus Position Statement on testosterone use in women (Wierman et al., 2019, Journal of Clinical Endocrinology and Metabolism) recommends targeting physiological premenopausal levels, typically 15 to 70 ng/dL, and cautions that supraphysiological dosing raises androgen excess risks including acne, hair loss, voice changes, and clitoral enlargement. Whether her dose produces supraphysiological levels depends on her individual metabolism and baseline levels, which she does not discuss.
What did they get wrong (or right)?
Credit where it's due: her dose is in a range that clinicians actually use, and she does not claim this protocol will cure anything or tell viewers to copy it. Those are two things a lot of hormone content creators get wrong, and she avoided both.
What she got wrong is the unit explanation. Saying "20 units equals four milligrams" only holds if her testosterone is compounded or formulated at 20mg/mL. Standard testosterone cypionate for men runs at 200mg/mL, which would make 20 units a 40mg dose, a very different and potentially dangerous amount for a woman. She never states her concentration. For a 48,000-person audience, that gap is not a minor oversight. Someone watching this, sourcing testosterone without a prescription, could draw a catastrophically different dose using the same syringe logic. That is the core failure of this video.
The three-times-weekly injection schedule is actually well-reasoned for managing peaks and troughs in subcutaneous testosterone delivery. That part is defensible.
What should you actually know?
Testosterone therapy for women is real medicine with real evidence behind specific indications, primarily hypoactive sexual desire disorder in postmenopausal women. It is not a general wellness optimization tool backed by strong long-term data, regardless of how it's framed in hashtags like "hormoneoptimization" or "feminineenergy."
The Endocrine Society and the British Menopause Society both recommend that women using testosterone therapy have baseline and follow-up bloodwork, including total testosterone levels, to avoid going supraphysiological. Self-dosing from social media, without knowing your baseline or tracking your labs, removes the only safety net the evidence actually supports.
Compounded testosterone preparations, which are likely what she's using given the concentration implied, are not FDA-approved for women in the United States. They are legal to prescribe and dispense under physician supervision, but they vary in concentration between pharmacies. That variability is exactly why her unit-based dosing explanation is dangerous to generalize. If you are interested in testosterone therapy, the conversation starts with a clinician who can order labs, not a TikTok syringe demonstration.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 8 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @taylorreidcoachin's testosterone routine claims fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
@taylorreidcoachin's testosterone routine claims fact-checked should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
Use the health tools and supporting evidence to prepare questions for your clinician.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The creator describes a subcutaneous testosterone regimen of approximately 12mg per week divided across three injections, implying a preparation concentrated at roughly 20mg/mL.
FormBlends verdict
The creator describes a subcutaneous testosterone regimen of approximately 12mg per week divided across three injections, implying a preparation concentrated at roughly 20mg/mL. This falls within the lower-to-mid range seen in some women's TRT protocols, but the Global Consensus Position Statement (Wierman et al., 2019) emphasizes that dosing in women must be guided by serum testosterone measurements to avoid supraphysiological androgen exposure. No mention of lab monitoring, baseline levels, or prescribing physician is made in the transcript.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes a subcutaneous testosterone regimen of approximately 12mg per week divided across three injections, implying a preparation concentrated at roughly 20mg/mL. This falls within the lower-to-mid range seen in some women's TRT protocols, but the Global Consensus Position Statement (Wierman et al., 2019) emphasizes that dosing in women must be guided by serum testosterone measurements to avoid supraphysiological androgen exposure. No mention of lab monitoring, baseline levels, or prescribing physician is made in the transcript.
- The Global Consensus Position Statement (Wierman et al., 2019, JCEM) recommends targeting physiological premenopausal testosterone levels in women, roughly 15 to 70 ng/dL, with regular lab monitoring to avoid androgen excess.
- 20 units on a syringe does not equal a fixed milligram dose. The milligram amount depends on the concentration of the specific formulation, which varies between compounding pharmacies.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Global Consensus Position Statement (Wierman et al., 2019, JCEM) recommends targeting physiological premenopausal testosterone levels in women, roughly 15 to 70 ng/dL, with regular lab monitoring to avoid androgen excess.
- 20 units on a syringe does not equal a fixed milligram dose. The milligram amount depends on the concentration of the specific formulation, which varies between compounding pharmacies.
- Davis et al. (2019, The Lancet Diabetes and Endocrinology) found testosterone improved sexual function in women but noted the absence of safety data beyond 24 months of use.
- Compounded testosterone preparations for women are not FDA-approved products in the United States. They are legally prescribed under physician supervision but are not equivalent to approved brand-name drugs.
- Androgen excess symptoms in women, including acne, hair thinning, and voice changes, are associated with supraphysiological testosterone levels. These risks increase without baseline and follow-up bloodwork.
- Three-times-weekly subcutaneous injection is a reasonable frequency strategy for reducing hormonal fluctuation, but frequency decisions should be made alongside a prescribing clinician reviewing lab results.
- Self-dosing testosterone based on social media content, without knowing your own baseline serum levels, eliminates the primary safeguard the clinical evidence supports.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
TaylorReidCoaching · TikTok creator
48.4K views on this video
My Testosterone Dosing Routine 💉✨ When it comes to testosterone therapy, finding the right dose is everything! I’ve dialed in a routine that keeps me feeling balanced, energized, and confident 💪💫 �
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by TaylorReidCoaching, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.